Clinical Trial Update: A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating AZR-MD-001 for abnormal Meibomian gland function in Dry Eye Disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Meibomian Gland Dysfunction

Drugs mentioned

• AZR-MD-001

Snippet

Sponsor: Azura Ophthalmics | Conditions: Dry Eye Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING